Chief Executive Officer
Scott Drake joined Spectranetics as the Chief Executive Officer in August 2011. Prior to joining Spectranetics Scott held the position of Senior Vice President, Operations of DaVita, Inc. (NYSE: DVA), a leading U.S. provider of kidney care and dialysis. At DaVita, he had responsibility for business operations that generated approximately 20% of the company’s revenue, which exceeds $6 billion. Previously, Mr. Drake held several positions of increasing responsibility within various healthcare business units at Covidien, Plc over a period of 17 years. From 2006 to 2009, Mr. Drake was Global Business Unit President, Respiratory and Monitoring Solutions, a $1.5 billion business with 8,000 employees. Under his leadership, significant operational improvements were made, including revenue and profit growth; enhanced new product development pipeline; lifting of FDA consent decree; and lean six sigma operational excellence initiatives. Foundational to these accomplishments is an intense focus on new product development, organizational effectiveness and customer needs. From 2003 to 2006, he was President, Valleylab (recently re-named Energy-Based Devices), a $375 million surgical device business, where organic revenue growth accelerated from 4% to 24% during his tenure. From 2001 to 2003, he was Vice President and General Manager, Critical Care, a $150 million business unit where revenue growth and operating profitability improved under his leadership. Prior to 2001, Mr. Drake held several positions in sales and marketing management within various medical device business units. Mr. Drake holds a B.S. in business administration from Miami University of Ohio.
Guy A. Childs
Chief Financial Officer
Guy A. Childs has served as Vice President, Chief Financial Officer since January 2003. In May 2002, Mr. Childs was appointed Acting Chief Financial Officer, a position he also held from May 1999 to December 1999. Since joining Spectranetics in September 1991, Mr. Childs has held various accounting and financial management positions, the most recent being Director of Finance, which he held from January 2000 to May 2002. Prior to joining Spectranetics, Mr. Childs worked for the public accounting firm of Deloitte & Touche, LLP serving as a senior accountant on various audit engagements in the financial services, healthcare and manufacturing industries.
Shahriar (Shar) Matin
Chief Operating Officer
In January 2014, Shar Matin was promoted to Chief Operating Officer with responsibilities that include oversight of operations, quality, field service, clinical, regulatory affairs, international commercial operations, and business development. He previously served as Senior Vice President of Operations, Business Development and International. In April 2010, Matin was named Senior Vice President, Product Development, Operations and International. He joined Spectranetics in March 2007 as the Managing Director of Europe, Russia and Middle East business. He was promoted to Vice President and Managing Director of International in March 2008. Before joining Spectranetics in March 2007, Matin served as the Business Unit Director for Boston Scientific Corporation’s Cardiac Rhythm Management operations in China. He also served in several executive, management, and engineering positions with Guidant Corporation, including General Manager of Southeast Asia and Pakistan, Clinical Sales Representative in the U.S., and Group Leader for Vascular Intervention Manufacturing Engineering in Ireland. Matin holds a Bachelor of Science degree in Mechanical Engineering from the University of California, Berkeley, with honors, and a Master of Business Administration degree from Harvard Business School.
Senior Vice President, Sales and Marketing, Vascular Intervention
Kimberly McIntosh Bridges joined Spectranetics in August 2013 as Senior Vice President, Sales and Marketing, Vascular Intervention. Prior to joining the company, Ms. Bridges held the position of Vice President, Sales and Marketing, at Blockade Medical in Irvine, CA, where she commercialized catheter- based therapeutic devices for the treatment of cerebral aneurysms. She played a key role in shaping corporate strategy, portfolio management and organizationally preparing the company for success beyond the start up stage. Prior to her role at Blockade Medical, she served as Vice President of U.S. Commercial Therapy Development and Global Acute Ischemic Stroke Marketing for Stryker Neurovascular. Stryker acquired Concentric Medical, Inc., in 2011, where she served as Vice President of Sales and Marketing for North America and Asia for almost five years. Before joining the neurovascular business, Ms. Bridges spent 11 years in peripheral and cardiology sales leadership roles within the Cordis division of Johnson & Johnson, Guidant Corporation and ev3, Inc. She received her Executive MBA at the University of Southern California Marshall School of Business and BS in Management from Pepperdine University.
Senior Vice President, Sales and Marketing, Lead Management
Donna Ford-Serbu, Senior Vice President, Sales and Marketing, Lead Management, joined Spectranetics as Senior Vice President Global Marketing, Strategy and Portfolio in October 2011. Prior to joining Spectranetics, Ms. Ford-Serbu held the position of Vice President, Global Marketing Patient Monitoring at Covidien. In this role she oversaw the global marketing function for the patient monitor business that represents over half of the revenue in Covidien’s Respiratory and Monitoring Solutions division. During her tenure as Vice President, Global Marketing Patient Monitoring, Donna drove efforts to transform the business from one focused solely on pulse oximetry to a broad monitoring platform with respiratory function and end organ perfusion monitoring. She led teams to improve the innovation pipeline and served as the integration lead for the $250 million acquisition of Aspect Medical in 2008 and commercial integration lead for the Somanetics acquisition in 2010. These efforts resulted in 32% growth of the patient monitoring business in three years. Prior to her role at Respiratory and Monitoring Solutions, Donna spent 10 years at the Energy-based Devices division at Covidien, holding positions of increasing responsibility in the areas of sales and marketing management, business development, and strategy and portfolio across the Electrosurgery, LigaSure and Interventional Oncology business lines. During her time as Business Director for the Interventional Oncology business, Donna led the integration of the Vivant Medical acquisition in 2005. Ms. Ford-Serbu holds an MBA from the University of Rochester, and a BS from the University of Colorado.
Senior Vice President, Global Human Resources
Robert Fuchs was named Senior Vice President, Global Human Resources in January 2014. In this role, Fuchs oversees all aspects of Global Human Resources and leads the company in its mission to “Attract, Retain and Develop the Best Talent on the Planet.” Fuchs has served in numerous human resources leadership positions in the high tech, telecommunications, mining, and service industries. Prior to joining Spectranetics in October 2012, he was Senior Vice President of Human Resources for EchoStar Communications, a high-tech engineering company with annual revenues of $3 billion. Prior to EchoStar Communications, Rob was Vice President of Human Resources for Dish Network, a digital television provider with annual revenues of $12 billion. Fuchs holds a Bachelor of Science Degree in Business Management from Ithaca College, New York.
Senior Vice President, General Counsel
Paul Gardon was named Senior Vice President, General Counsel in January 2014. He has practiced law for over 20 years and is responsible for oversight of all legal matters pertaining to Spectranetics. Prior to joining the organization in early 2012, Gardon served as General Counsel for a business unit of DaVita, a leading provider of kidney care and dialysis services, with revenues in excess of $1 billion. From 2004 to 2010, he held numerous positions of increasing responsibility at Covidien, including Vice President of Legal Affairs for two large divisions. He holds a Bachelor of Science degree from Marquette University and a Juris Doctor from the Villanova University School of Law.
Wade A. Bowe
Vice President, Research & Development
Wade Bowe joined Spectranetics in March, 2003 and in his current role as Vice President Research & Development drives all aspects of research, technical innovation, and new product development. Mr. Bowe has over 20 years medical device industry experience in diverse technical, leadership and management roles spanning Research & Development, Operations, and Program Management. He is the Inventor/Co-Inventor of 28 U.S. Patents and co-author of several publications. Prior to joining Spectranetics, Mr. Bowe spent twelve years in Research & Development and Operations with the Guidant Corporation. Mr. Bowe graduated with honors from GMI Engineering & Management Institute (Kettering University). He holds a Bachelor of Science degree in Mechanical Engineering.
Austin B. Byrd
Vice President and Chief Compliance Officer
Austin B. Byrd joined Spectranetics as the Vice President and Chief Compliance Officer in December 2012. Mr. Byrd is a veteran medical device executive and healthcare compliance officer with a wide-ranging legal background. From 2004 to 2011, Mr. Byrd was an in-house attorney and executive at Smith & Nephew, one of the world’s largest medical device companies. There he gained a reputation for balanced, practical legal and business risk advice.
As in-house counsel, Mr. Byrd oversaw the creation and management of Smith & Nephew’s consulting and product design contracts with health care professionals. He became the Orthopaedic Division’s first full-time compliance officer in 2005. From 2007 through 2010, Mr. Byrd was the company’s primary point of contact with the Department of Justice and Health and Human Services Department’s Office of the Inspector General (HHS-OIG). As Senior Vice President of Smith & Nephew’s InVentures business franchise, Mr. Byrd led an innovative team that engineered and produced patient-specific orthopedic instruments and implants through coordinated engineering centers in Memphis, Switzerland and India.
Prior to joining Smith & Nephew, Mr. Byrd was an associate attorney at Wyatt, Tarrant & Combs, LLP, one of nation’s leading multi-specialty regional law firms. He focused on business and corporate legal matters including mergers and acquisitions, commercial real estate and lending, intellectual property licensing, creditors’ rights, and the formation and tax-exempt qualification of non-profit organizations. Mr. Byrd earned his Bachelor of Arts degree from Memphis State University and graduated from University of Memphis, Cecil D. Humphreys School of Law, JD, cum laude.